REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad de Hematologia y Oncologia de Santander S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Unidad de Hematologia y Oncologia de Santander S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Unidad de Hematologia y Oncologia de Santander S.A.S. is based in Colombia. The head office is in Bucaramanga. The company operates in the Ambulatory Health Care Services sector. Unidad de Hematologia y Oncologia de Santander S.A.S. was incorporated on August 04, 2010. There are currently 18 (2025) people employed by Unidad de Hematologia y Oncologia de Santander S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 8.93% in 2025. Its’ total assets recorded a growth of 8.93%. In 2025, Unidad de Hematologia y Oncologia de Santander S.A.S.’s net profit margin increased by 22.29%.

Headquarters
Cra. 36 # 48-98
Bucaramanga; Santander;

Contact Details: Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.

Website: http://www.unidhos.com.co

Basic Information
Total Employees:
Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.
Registered Capital:
Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.
Financial Auditors:
Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.
Incorporation Date:
August 04, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad de Hematologia y Oncologia de Santander S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
8.93%
Total Operating Revenue
8.93%
Operating Profit
105.71%
EBITDA
105.74%
Net Profit/Loss for the Period
387.95%
Total Assets
8.93%
Total Equity
190.16%
Operating Profit Margin
14.9%
Net Profit Margin
22.29%
Return on Equity (ROE)
24.68%
Debt / Equity
-35.94%
Quick Ratio
0.68%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?